Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B 12 Production by Intestinal Symbionts.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study with no human or animal subject data.
PubMed 28928206 · doi:10.1128/mBio.00770-17
What was done
Researchers conducted in vitro coculturing experiments pairing the host mucus-degrading bacterium *Akkermansia muciniphila* with non-mucus-degrading, butyrate-producing intestinal bacteria (*Anaerostipes caccae*, *Eubacterium hallii*, and *Faecalibacterium prausnitzii*) to assess metabolic syntrophy and metabolite production.
What was found
The abstract reports no numerical values. Coculturing *A. muciniphila* with *A. caccae*, *E. hallii*, and *F. prausnitzii* enabled syntrophic bacterial growth and butyrate synthesis from mucus-derived substrates. Additionally, pseudovitamin B12 generated by *E. hallii* supported propionate production by *A. muciniphila*, demonstrating bidirectional metabolic cross-feeding.
Why it matters
These findings provide a proof of concept that intestinal butyrate, propionate, and vitamin production can occur independently of dietary carbohydrates via mucosal glycan degradation.
Limits
The experiments were conducted entirely in vitro using simplified multi-species cocultures, which may not reflect the complexity of a complete gut microbiome or in vivo host-mucus dynamics. No quantitative metrics, concentrations, or human physiological outcomes were provided in the abstract.
Cited by
- supports Some patients have high levels of Akkermansia muciniphila in their microbiome yet fail to produce significant levels of short-chain fatty acids.